1. The Family: Bleomycins
Bleomycin is the name of a broad family of glycopeptide antibiotics produced by the bacterium Streptomyces verticillus. In a clinical context, “Bleomycin” usually refers to a mixture used in chemotherapy. In the lab, it is the parent category for all these drugs.
2. The Molecule: Phleomycin D1
Phleomycin D1 is a specific chemical member of the Bleomycin family. While Bleomycin and Phleomycin are very similar, Phleomycin has a slightly different chemical structure (a saturated bithiazole ring) that makes it more effective at killing certain types of cells, particularly fungi and some yeasts, that might be less sensitive to standard Bleomycin.
3. The Product: Zeocin™
Zeocin is the commercial trade name (trademarked by InvivoGen) for a specific formulation of Phleomycin D1.
- The “Blue” Color: Zeocin is copper-chelated (bound to copper ions), which gives the solution its distinct blue color. This chelated form is actually inactive.
- How it works: Once Zeocin enters your HEK293A cells, the copper is removed by internal cell processes. This “activates” the drug, allowing it to bind and cut the cell’s DNA.
| Name | What it is | Primary Use |
| Bleomycin | The “Family” name | Clinical chemotherapy; research. |
| Phleomycin D1 | The “Chemical” name | Scientific research; often used for fungi/yeast. |
| Zeocin | The “Brand” name | Standard selection for mammalian (HEK293) and bacterial cells. |